Rank | Gene Set | Z-score |
---|---|---|
1 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 6.43502178 |
2 | signal peptide processing (GO:0006465) | 5.98935436 |
3 | protein retention in ER lumen (GO:0006621) | 5.51449024 |
4 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 5.43360373 |
5 | COPII vesicle coating (GO:0048208) | 5.39230616 |
6 | protein maturation by protein folding (GO:0022417) | 5.16409038 |
7 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.80552290 |
8 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.76389453 |
9 | positive regulation of nuclease activity (GO:0032075) | 4.73696368 |
10 | establishment of integrated proviral latency (GO:0075713) | 4.63276398 |
11 | regulation of nuclease activity (GO:0032069) | 4.44812190 |
12 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.22022418 |
13 | tRNA aminoacylation for protein translation (GO:0006418) | 4.13519554 |
14 | cellular response to unfolded protein (GO:0034620) | 4.10751675 |
15 | establishment of viral latency (GO:0019043) | 4.08820263 |
16 | vesicle coating (GO:0006901) | 4.07566614 |
17 | ER overload response (GO:0006983) | 4.06542546 |
18 | tRNA aminoacylation (GO:0043039) | 4.04982772 |
19 | amino acid activation (GO:0043038) | 4.04982772 |
20 | sequestering of metal ion (GO:0051238) | 4.02477009 |
21 | pteridine-containing compound biosynthetic process (GO:0042559) | 4.01764837 |
22 | endocrine pancreas development (GO:0031018) | 4.01098736 |
23 | exocrine pancreas development (GO:0031017) | 3.99799204 |
24 | ribosome assembly (GO:0042255) | 3.99592522 |
25 | nuclear pore complex assembly (GO:0051292) | 3.97023266 |
26 | cellular response to topologically incorrect protein (GO:0035967) | 3.96348173 |
27 | ER-nucleus signaling pathway (GO:0006984) | 3.90461547 |
28 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.81959715 |
29 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.75907554 |
30 | proteasome assembly (GO:0043248) | 3.74230451 |
31 | peptidyl-asparagine modification (GO:0018196) | 3.71670345 |
32 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.60065847 |
33 | nuclear pore organization (GO:0006999) | 3.59762614 |
34 | peptide catabolic process (GO:0043171) | 3.56954424 |
35 | regulation of translational fidelity (GO:0006450) | 3.55260299 |
36 | peptide hormone processing (GO:0016486) | 3.52668335 |
37 | intestinal cholesterol absorption (GO:0030299) | 3.51511397 |
38 | response to endoplasmic reticulum stress (GO:0034976) | 3.48809945 |
39 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.48605392 |
40 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.48070252 |
41 | protein N-linked glycosylation (GO:0006487) | 3.46579543 |
42 | nucleobase biosynthetic process (GO:0046112) | 3.42636152 |
43 | GDP-mannose metabolic process (GO:0019673) | 3.42038678 |
44 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.41199592 |
45 | negative regulation of ligase activity (GO:0051352) | 3.37753389 |
46 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.37753389 |
47 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.34829468 |
48 | pore complex assembly (GO:0046931) | 3.34259842 |
49 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.33060493 |
50 | non-recombinational repair (GO:0000726) | 3.33060493 |
51 | fatty acid elongation (GO:0030497) | 3.32597105 |
52 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.29176832 |
53 | response to unfolded protein (GO:0006986) | 3.25948920 |
54 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.25711079 |
55 | glandular epithelial cell differentiation (GO:0002067) | 3.22379306 |
56 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.22074463 |
57 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.20217223 |
58 | proline biosynthetic process (GO:0006561) | 3.18443691 |
59 | response to topologically incorrect protein (GO:0035966) | 3.17095793 |
60 | tetrahydrofolate metabolic process (GO:0046653) | 3.14811615 |
61 | intestinal absorption (GO:0050892) | 3.12340506 |
62 | NADPH regeneration (GO:0006740) | 3.09957411 |
63 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.09557457 |
64 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.09557457 |
65 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.07980876 |
66 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.07510690 |
67 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.07510690 |
68 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.06843246 |
69 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.06843246 |
70 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.06843246 |
71 | * ER to Golgi vesicle-mediated transport (GO:0006888) | 3.01405793 |
72 | IMP biosynthetic process (GO:0006188) | 3.00531101 |
73 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.00492195 |
74 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.99442167 |
75 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.98182783 |
76 | protein autoprocessing (GO:0016540) | 2.97791511 |
77 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.93321822 |
78 | mitotic nuclear envelope disassembly (GO:0007077) | 2.92499549 |
79 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.91899697 |
80 | tricarboxylic acid cycle (GO:0006099) | 2.91865211 |
81 | positive regulation of ligase activity (GO:0051351) | 2.89169962 |
82 | purine nucleobase biosynthetic process (GO:0009113) | 2.89065326 |
83 | ribosome biogenesis (GO:0042254) | 2.88996741 |
84 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.86971534 |
85 | 4-hydroxyproline metabolic process (GO:0019471) | 2.86552304 |
86 | mitotic metaphase plate congression (GO:0007080) | 2.86070456 |
87 | de novo protein folding (GO:0006458) | 2.83629739 |
88 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.82834766 |
89 | regulation of mitochondrial translation (GO:0070129) | 2.80707757 |
90 | regulation of translational termination (GO:0006449) | 2.80223919 |
91 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.79949480 |
92 | de novo posttranslational protein folding (GO:0051084) | 2.79433805 |
93 | folic acid metabolic process (GO:0046655) | 2.78686509 |
94 | folic acid-containing compound metabolic process (GO:0006760) | 2.77086268 |
95 | regulation of translation in response to stress (GO:0043555) | 2.77051630 |
96 | valine metabolic process (GO:0006573) | 2.76568157 |
97 | pteridine-containing compound metabolic process (GO:0042558) | 2.74601396 |
98 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.74280700 |
99 | cell redox homeostasis (GO:0045454) | 2.72970614 |
100 | cullin deneddylation (GO:0010388) | 2.72630060 |
101 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.71201651 |
102 | UMP metabolic process (GO:0046049) | 2.71201651 |
103 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.71201651 |
104 | UMP biosynthetic process (GO:0006222) | 2.71201651 |
105 | L-serine metabolic process (GO:0006563) | 2.70815424 |
106 | protein deneddylation (GO:0000338) | 2.70763563 |
107 | membrane disassembly (GO:0030397) | 2.69548096 |
108 | nuclear envelope disassembly (GO:0051081) | 2.69548096 |
109 | regulation of ligase activity (GO:0051340) | 2.67732510 |
110 | hyperosmotic salinity response (GO:0042538) | 2.67599326 |
111 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.67176556 |
112 | DNA ligation (GO:0006266) | 2.66766334 |
113 | positive regulation of immune response to tumor cell (GO:0002839) | 2.65570050 |
114 | regulation of immune response to tumor cell (GO:0002837) | 2.65570050 |
115 | regulation of response to tumor cell (GO:0002834) | 2.65570050 |
116 | positive regulation of response to tumor cell (GO:0002836) | 2.65570050 |
117 | spliceosomal snRNP assembly (GO:0000387) | 2.61269619 |
118 | formation of translation preinitiation complex (GO:0001731) | 2.61076279 |
119 | intestinal epithelial cell development (GO:0060576) | 2.60012050 |
120 | mitotic chromosome condensation (GO:0007076) | 2.59526941 |
121 | alpha-linolenic acid metabolic process (GO:0036109) | 2.59176236 |
122 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.55747455 |
123 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.53834200 |
124 | mitochondrial DNA metabolic process (GO:0032042) | 2.53207893 |
125 | mitochondrial RNA metabolic process (GO:0000959) | 2.52884752 |
126 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.52039540 |
127 | metaphase plate congression (GO:0051310) | 2.51932317 |
128 | nucleotide transmembrane transport (GO:1901679) | 2.51238592 |
129 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.50497984 |
130 | mitotic sister chromatid segregation (GO:0000070) | 2.50460389 |
131 | glucose 6-phosphate metabolic process (GO:0051156) | 2.49814847 |
132 | telomere maintenance via recombination (GO:0000722) | 2.49528400 |
133 | regulation of translational elongation (GO:0006448) | 2.48834461 |
134 | regulation of cellular amine metabolic process (GO:0033238) | 2.48573815 |
135 | type B pancreatic cell development (GO:0003323) | 2.47910440 |
136 | IMP metabolic process (GO:0046040) | 2.46724533 |
137 | cellular response to glucose starvation (GO:0042149) | 2.46146477 |
138 | proline metabolic process (GO:0006560) | 2.45776295 |
139 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.44994878 |
140 | cell cycle G1/S phase transition (GO:0044843) | 2.44994878 |
141 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.42772360 |
142 | L-phenylalanine catabolic process (GO:0006559) | 2.42772360 |
143 | DNA strand elongation (GO:0022616) | 2.41450255 |
144 | peptide metabolic process (GO:0006518) | 2.38692800 |
145 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.38537410 |
146 | L-phenylalanine metabolic process (GO:0006558) | 2.38122212 |
147 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.38122212 |
148 | nucleotide-sugar metabolic process (GO:0009225) | 2.37654661 |
149 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.37568125 |
150 | cellular zinc ion homeostasis (GO:0006882) | 2.37486168 |
151 | tricarboxylic acid metabolic process (GO:0072350) | 2.37137073 |
152 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.37091477 |
153 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.37091477 |
154 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.36151962 |
155 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.36151962 |
156 | serine family amino acid biosynthetic process (GO:0009070) | 2.32990292 |
157 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.32361314 |
158 | DNA unwinding involved in DNA replication (GO:0006268) | 2.29853451 |
159 | chaperone-mediated protein folding (GO:0061077) | 2.29639118 |
160 | one-carbon metabolic process (GO:0006730) | 2.28815393 |
161 | hormone catabolic process (GO:0042447) | 2.26097904 |
162 | Golgi organization (GO:0007030) | 2.24826066 |
163 | glandular epithelial cell development (GO:0002068) | 2.24617523 |
164 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.24605130 |
165 | pentose-phosphate shunt (GO:0006098) | 2.24064926 |
166 | cysteine metabolic process (GO:0006534) | 2.24032217 |
167 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.23217477 |
168 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.23025651 |
169 | maintenance of protein localization in organelle (GO:0072595) | 2.23001044 |
170 | digestion (GO:0007586) | 2.22599339 |
171 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.22459264 |
172 | positive regulation of insulin secretion (GO:0032024) | 2.21734225 |
173 | Golgi transport vesicle coating (GO:0048200) | 10.1515184 |
174 | COPI coating of Golgi vesicle (GO:0048205) | 10.1515184 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.39065540 |
2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.13257732 |
3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.22586199 |
4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.89754662 |
5 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.88340484 |
6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.83746799 |
7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.70302137 |
8 | GATA1_22025678_ChIP-Seq_K562_Human | 2.57357797 |
9 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.56619871 |
10 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.55348957 |
11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.47626070 |
12 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.40348750 |
13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.38531088 |
14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.29609829 |
15 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.19121003 |
16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.04636027 |
17 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.00545574 |
18 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.00395714 |
19 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.99303137 |
20 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.98747298 |
21 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.96973848 |
22 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.94127220 |
23 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92884830 |
24 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.91911135 |
25 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.91087784 |
26 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.87840566 |
27 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.87414349 |
28 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.84817560 |
29 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.80445171 |
30 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.80186271 |
31 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.79688874 |
32 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.76924682 |
33 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.74783062 |
34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.73008645 |
35 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.72748646 |
36 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.72705613 |
37 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.71419021 |
38 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.68292886 |
39 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.67779782 |
40 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.66834506 |
41 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.64551548 |
42 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.64316961 |
43 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.63967554 |
44 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.62007541 |
45 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.58459806 |
46 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.58419211 |
47 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.57571004 |
48 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.54727867 |
49 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.53860256 |
50 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.52327155 |
51 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.52244043 |
52 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.50320384 |
53 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.49879401 |
54 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.49336255 |
55 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48514655 |
56 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.48362752 |
57 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.46544116 |
58 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.46213085 |
59 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45557211 |
60 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.43791659 |
61 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.42566518 |
62 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.42293040 |
63 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.38936522 |
64 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34601215 |
65 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.34599850 |
66 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.34041703 |
67 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.33508013 |
68 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.33005344 |
69 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.32780190 |
70 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.32605184 |
71 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.27427566 |
72 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.26525949 |
73 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.25565199 |
74 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.25369831 |
75 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.25342148 |
76 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.25287843 |
77 | MYC_22102868_ChIP-Seq_BL_Human | 1.24117982 |
78 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.24099921 |
79 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.20545642 |
80 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.18271638 |
81 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.17304719 |
82 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.12629223 |
83 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.12064864 |
84 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.10050303 |
85 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.09382339 |
86 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.07368674 |
87 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.06063678 |
88 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03970375 |
89 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.03688775 |
90 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.03282857 |
91 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.03124966 |
92 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.02744609 |
93 | * YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.02710833 |
94 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.01660224 |
95 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.00315909 |
96 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.00258531 |
97 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.00214907 |
98 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.97144554 |
99 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97109493 |
100 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.95127897 |
101 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.94540563 |
102 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.94155589 |
103 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.94143677 |
104 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.94120749 |
105 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.93937967 |
106 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.92741123 |
107 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.91939762 |
108 | MYB_26560356_Chip-Seq_TH2_Human | 0.91695003 |
109 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.91373181 |
110 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.90713026 |
111 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.90521390 |
112 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.89595739 |
113 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.89573719 |
114 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.89400372 |
115 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.89198620 |
116 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.89078346 |
117 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.85888274 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003806_abnormal_nucleotide_metabolis | 3.32439812 |
2 | MP0002877_abnormal_melanocyte_morpholog | 3.08181769 |
3 | MP0004264_abnormal_extraembryonic_tissu | 2.97965502 |
4 | MP0005220_abnormal_exocrine_pancreas | 2.92494358 |
5 | MP0003183_abnormal_peptide_metabolism | 2.88886379 |
6 | MP0008260_abnormal_autophagy | 2.85104027 |
7 | MP0002139_abnormal_hepatobiliary_system | 2.78816204 |
8 | MP0003195_calcinosis | 2.78637306 |
9 | MP0001666_abnormal_nutrient_absorption | 2.67700583 |
10 | MP0004043_abnormal_pH_regulation | 2.65478955 |
11 | MP0003693_abnormal_embryo_hatching | 2.64386218 |
12 | MP0002693_abnormal_pancreas_physiology | 2.56883281 |
13 | MP0005365_abnormal_bile_salt | 2.54051864 |
14 | MP0001944_abnormal_pancreas_morphology | 2.30253116 |
15 | MP0005083_abnormal_biliary_tract | 2.19173256 |
16 | MP0005451_abnormal_body_composition | 2.15360874 |
17 | MP0006054_spinal_hemorrhage | 2.04424385 |
18 | MP0003283_abnormal_digestive_organ | 1.97516554 |
19 | MP0003300_gastrointestinal_ulcer | 1.95674499 |
20 | MP0008057_abnormal_DNA_replication | 1.94474590 |
21 | MP0005360_urolithiasis | 1.91792724 |
22 | MP0004957_abnormal_blastocyst_morpholog | 1.91231963 |
23 | MP0000678_abnormal_parathyroid_gland | 1.86691624 |
24 | MP0002138_abnormal_hepatobiliary_system | 1.83547042 |
25 | MP0005085_abnormal_gallbladder_physiolo | 1.82569141 |
26 | MP0009643_abnormal_urine_homeostasis | 1.81656483 |
27 | MP0003941_abnormal_skin_development | 1.80947685 |
28 | MP0003786_premature_aging | 1.79217115 |
29 | MP0003718_maternal_effect | 1.78632569 |
30 | MP0010352_gastrointestinal_tract_polyps | 1.72551824 |
31 | MP0000013_abnormal_adipose_tissue | 1.71487904 |
32 | MP0005058_abnormal_lysosome_morphology | 1.70626406 |
33 | MP0002796_impaired_skin_barrier | 1.68873626 |
34 | MP0002163_abnormal_gland_morphology | 1.59755888 |
35 | MP0006035_abnormal_mitochondrial_morpho | 1.55016773 |
36 | MP0003186_abnormal_redox_activity | 1.54567377 |
37 | MP0003252_abnormal_bile_duct | 1.51609080 |
38 | MP0005501_abnormal_skin_physiology | 1.50570292 |
39 | MP0009780_abnormal_chondrocyte_physiolo | 1.48047702 |
40 | MP0009840_abnormal_foam_cell | 1.47891408 |
41 | MP0001216_abnormal_epidermal_layer | 1.47013591 |
42 | MP0003868_abnormal_feces_composition | 1.45849534 |
43 | MP0010678_abnormal_skin_adnexa | 1.36806024 |
44 | MP0001727_abnormal_embryo_implantation | 1.34334512 |
45 | MP0005408_hypopigmentation | 1.33339695 |
46 | MP0002078_abnormal_glucose_homeostasis | 1.30932433 |
47 | MP0010234_abnormal_vibrissa_follicle | 1.30851786 |
48 | MP0003077_abnormal_cell_cycle | 1.29379404 |
49 | MP0001672_abnormal_embryogenesis/_devel | 1.28175677 |
50 | MP0005380_embryogenesis_phenotype | 1.28175677 |
51 | MP0001756_abnormal_urination | 1.27813498 |
52 | MP0008875_abnormal_xenobiotic_pharmacok | 1.24003980 |
53 | MP0005379_endocrine/exocrine_gland_phen | 1.22990178 |
54 | MP0002090_abnormal_vision | 1.22333666 |
55 | MP0003221_abnormal_cardiomyocyte_apopto | 1.22276611 |
56 | MP0002928_abnormal_bile_duct | 1.22186284 |
57 | MP0000627_abnormal_mammary_gland | 1.22050636 |
58 | MP0005384_cellular_phenotype | 1.21288695 |
59 | MP0002909_abnormal_adrenal_gland | 1.20986390 |
60 | MP0005332_abnormal_amino_acid | 1.20420184 |
61 | MP0005636_abnormal_mineral_homeostasis | 1.19597174 |
62 | MP0000313_abnormal_cell_death | 1.19539743 |
63 | MP0003436_decreased_susceptibility_to | 1.19233061 |
64 | MP0001915_intracranial_hemorrhage | 1.16536734 |
65 | MP0003453_abnormal_keratinocyte_physiol | 1.16052771 |
66 | MP0003315_abnormal_perineum_morphology | 1.15476422 |
67 | MP0003866_abnormal_defecation | 1.13187133 |
68 | MP0001764_abnormal_homeostasis | 1.12515158 |
69 | MP0003984_embryonic_growth_retardation | 1.12513794 |
70 | MP0005084_abnormal_gallbladder_morpholo | 1.12160001 |
71 | MP0002098_abnormal_vibrissa_morphology | 1.12055402 |
72 | MP0010307_abnormal_tumor_latency | 1.12041397 |
73 | MP0004233_abnormal_muscle_weight | 1.10833770 |
74 | MP0003111_abnormal_nucleus_morphology | 1.07774993 |
75 | MP0009697_abnormal_copulation | 1.06861577 |
76 | MP0002088_abnormal_embryonic_growth/wei | 1.06510021 |
77 | MP0001346_abnormal_lacrimal_gland | 1.05980600 |
78 | MP0005621_abnormal_cell_physiology | 1.05203024 |
79 | MP0000609_abnormal_liver_physiology | 1.04426838 |
80 | MP0010094_abnormal_chromosome_stability | 1.03219293 |
81 | MP0000613_abnormal_salivary_gland | 1.02831851 |
82 | MP0003656_abnormal_erythrocyte_physiolo | 1.02436622 |
83 | MP0001765_abnormal_ion_homeostasis | 1.02271331 |
84 | MP0001529_abnormal_vocalization | 1.02150118 |
85 | MP0001881_abnormal_mammary_gland | 1.01166575 |
86 | MP0010386_abnormal_urinary_bladder | 1.00983568 |
87 | MP0002086_abnormal_extraembryonic_tissu | 0.99909503 |
88 | MP0001661_extended_life_span | 0.97791924 |
89 | MP0004782_abnormal_surfactant_physiolog | 0.97539157 |
90 | MP0001730_embryonic_growth_arrest | 0.97365669 |
91 | MP0000490_abnormal_crypts_of | 0.97292976 |
92 | MP0001853_heart_inflammation | 0.96397447 |
93 | MP0005310_abnormal_salivary_gland | 0.93743536 |
94 | MP0008007_abnormal_cellular_replicative | 0.92151579 |
95 | MP0008932_abnormal_embryonic_tissue | 0.91990471 |
96 | MP0000598_abnormal_liver_morphology | 0.91556094 |
97 | MP0000003_abnormal_adipose_tissue | 0.91228023 |
98 | MP0003172_abnormal_lysosome_physiology | 0.91061796 |
99 | MP0000377_abnormal_hair_follicle | 0.90543298 |
100 | MP0001845_abnormal_inflammatory_respons | 0.90247777 |
101 | MP0006082_CNS_inflammation | 0.89697667 |
102 | MP0005076_abnormal_cell_differentiation | 0.89390833 |
103 | MP0002006_tumorigenesis | 0.88494190 |
104 | MP0000647_abnormal_sebaceous_gland | 0.88476551 |
105 | MP0008058_abnormal_DNA_repair | 0.87422985 |
106 | MP0004019_abnormal_vitamin_homeostasis | 0.86967384 |
107 | MP0000462_abnormal_digestive_system | 0.86274892 |
108 | MP0003890_abnormal_embryonic-extraembry | 0.84831446 |
109 | MP0002084_abnormal_developmental_patter | 0.82923507 |
110 | MP0002166_altered_tumor_susceptibility | 0.82111282 |
111 | MP0005319_abnormal_enzyme/_coenzyme | 0.81980678 |
112 | MP0002896_abnormal_bone_mineralization | 0.81709681 |
113 | MP0010155_abnormal_intestine_physiology | 0.80902190 |
114 | MP0002060_abnormal_skin_morphology | 0.80640795 |
115 | MP0000579_abnormal_nail_morphology | 0.80417069 |
116 | MP0000858_altered_metastatic_potential | 0.80302600 |
117 | MP0006036_abnormal_mitochondrial_physio | 0.79995625 |
118 | MP0003705_abnormal_hypodermis_morpholog | 0.79614427 |
119 | MP0003763_abnormal_thymus_physiology | 0.79268948 |
120 | MP0008469_abnormal_protein_level | 0.77519554 |
121 | MP0003959_abnormal_lean_body | 0.77186419 |
122 | MP0001533_abnormal_skeleton_physiology | 0.75692648 |
123 | MP0003566_abnormal_cell_adhesion | 0.75264670 |
124 | MP0002085_abnormal_embryonic_tissue | 0.75090207 |
125 | MP0009333_abnormal_splenocyte_physiolog | 0.74584146 |
126 | MP0000350_abnormal_cell_proliferation | 0.74427167 |
127 | MP0010329_abnormal_lipoprotein_level | 0.74009067 |
128 | MP0003953_abnormal_hormone_level | 0.73909989 |
129 | MP0000358_abnormal_cell_content/ | 0.73769875 |
130 | MP0000685_abnormal_immune_system | 0.71994285 |
131 | MP0003795_abnormal_bone_structure | 0.71890405 |
132 | MP0005395_other_phenotype | 0.71673732 |
133 | MP0005499_abnormal_olfactory_system | 0.70290693 |
134 | MP0005394_taste/olfaction_phenotype | 0.70290693 |
135 | MP0002136_abnormal_kidney_physiology | 0.70096946 |
136 | MP0003943_abnormal_hepatobiliary_system | 0.69839056 |
137 | MP0002118_abnormal_lipid_homeostasis | 0.69595796 |
138 | MP0000477_abnormal_intestine_morphology | 0.69048217 |
139 | MP0000604_amyloidosis | 0.68955915 |
140 | MP0009672_abnormal_birth_weight | 0.68622617 |
141 | MP0002080_prenatal_lethality | 0.68576613 |
142 | MP0002876_abnormal_thyroid_physiology | 0.68484022 |
143 | MP0004197_abnormal_fetal_growth/weight/ | 0.68079544 |
144 | MP0004947_skin_inflammation | 0.67135829 |
145 | MP0009642_abnormal_blood_homeostasis | 0.66357065 |
146 | MP0002019_abnormal_tumor_incidence | 0.66280442 |
147 | MP0005000_abnormal_immune_tolerance | 0.64721295 |
148 | MP0009785_altered_susceptibility_to | 0.63063557 |
149 | MP0003191_abnormal_cellular_cholesterol | 0.63051276 |
150 | MP0001697_abnormal_embryo_size | 0.62656412 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.59097397 |
2 | Hypoglycemic seizures (HP:0002173) | 4.42962547 |
3 | Hypoglycemic coma (HP:0001325) | 4.32171980 |
4 | Symptomatic seizures (HP:0011145) | 4.08554222 |
5 | Abnormality of glycolysis (HP:0004366) | 3.92406272 |
6 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.88531893 |
7 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.88531893 |
8 | Microvesicular hepatic steatosis (HP:0001414) | 3.78722499 |
9 | Abnormality of the intrinsic pathway (HP:0010989) | 3.71152681 |
10 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.58752648 |
11 | Increased serum pyruvate (HP:0003542) | 3.51683172 |
12 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.45301697 |
13 | Ketoacidosis (HP:0001993) | 3.34327111 |
14 | Generalized aminoaciduria (HP:0002909) | 3.32692866 |
15 | Late onset (HP:0003584) | 3.27751328 |
16 | Abnormal protein glycosylation (HP:0012346) | 3.25127655 |
17 | Abnormal glycosylation (HP:0012345) | 3.25127655 |
18 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.25127655 |
19 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.25127655 |
20 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.17525441 |
21 | Type I transferrin isoform profile (HP:0003642) | 3.15747438 |
22 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.15027388 |
23 | Abnormal gallbladder physiology (HP:0012438) | 3.09016864 |
24 | Cholecystitis (HP:0001082) | 3.09016864 |
25 | Gout (HP:0001997) | 3.06737292 |
26 | Vacuolated lymphocytes (HP:0001922) | 3.03574012 |
27 | Hyperglycemia (HP:0003074) | 2.89544917 |
28 | Abnormal pancreas size (HP:0012094) | 2.83102247 |
29 | Abnormality of the common coagulation pathway (HP:0010990) | 2.80880802 |
30 | Cortical dysplasia (HP:0002539) | 2.70973989 |
31 | Dysostosis multiplex (HP:0000943) | 2.69890715 |
32 | Loss of speech (HP:0002371) | 2.66533420 |
33 | Intrahepatic cholestasis (HP:0001406) | 2.63188520 |
34 | Hypokinesia (HP:0002375) | 2.58651028 |
35 | Conjugated hyperbilirubinemia (HP:0002908) | 2.58049053 |
36 | Mucopolysacchariduria (HP:0008155) | 2.56818164 |
37 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.56818164 |
38 | Reduced antithrombin III activity (HP:0001976) | 2.55379241 |
39 | Degeneration of anterior horn cells (HP:0002398) | 2.49348981 |
40 | Abnormality of the anterior horn cell (HP:0006802) | 2.49348981 |
41 | Fat malabsorption (HP:0002630) | 2.43762939 |
42 | Prominent metopic ridge (HP:0005487) | 2.43124637 |
43 | Ketosis (HP:0001946) | 2.39195438 |
44 | Abnormality of T cell physiology (HP:0011840) | 2.34165243 |
45 | Thoracolumbar scoliosis (HP:0002944) | 2.33728197 |
46 | Multiple enchondromatosis (HP:0005701) | 2.33367099 |
47 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.31991415 |
48 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.30644448 |
49 | Abnormality of purine metabolism (HP:0004352) | 2.29676934 |
50 | Exocrine pancreatic insufficiency (HP:0001738) | 2.29124318 |
51 | Limb hypertonia (HP:0002509) | 2.27827977 |
52 | Upper limb muscle weakness (HP:0003484) | 2.27316803 |
53 | Insulin resistance (HP:0000855) | 2.26076367 |
54 | Septate vagina (HP:0001153) | 2.25996418 |
55 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.23130931 |
56 | Large for gestational age (HP:0001520) | 2.21430950 |
57 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.21216226 |
58 | 11 pairs of ribs (HP:0000878) | 2.20631354 |
59 | Megaloblastic anemia (HP:0001889) | 2.20568366 |
60 | Abnormality of nucleobase metabolism (HP:0010932) | 2.20434731 |
61 | Micronodular cirrhosis (HP:0001413) | 2.19819334 |
62 | Death in infancy (HP:0001522) | 2.19318466 |
63 | Secondary amenorrhea (HP:0000869) | 2.18898786 |
64 | Overlapping toe (HP:0001845) | 2.18449227 |
65 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.17450996 |
66 | Sparse eyelashes (HP:0000653) | 2.16375703 |
67 | Orthostatic hypotension (HP:0001278) | 2.15408990 |
68 | Spastic diplegia (HP:0001264) | 2.15358003 |
69 | Abnormal foot bone ossification (HP:0010675) | 2.15242486 |
70 | Metaphyseal cupping (HP:0003021) | 2.14770575 |
71 | Tetraparesis (HP:0002273) | 2.14615602 |
72 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.14481783 |
73 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.14481783 |
74 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.14481783 |
75 | Postnatal microcephaly (HP:0005484) | 2.13609017 |
76 | Entropion (HP:0000621) | 2.12306516 |
77 | Rough bone trabeculation (HP:0100670) | 2.11910804 |
78 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.11349893 |
79 | Progressive external ophthalmoplegia (HP:0000590) | 2.08264252 |
80 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.07245662 |
81 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.07245662 |
82 | Abnormality of glycolipid metabolism (HP:0010969) | 2.07245662 |
83 | Oral leukoplakia (HP:0002745) | 2.07236294 |
84 | Cutaneous melanoma (HP:0012056) | 2.07183482 |
85 | Abnormal biliary tract morphology (HP:0012440) | 2.06539558 |
86 | Thrombocytosis (HP:0001894) | 2.06386680 |
87 | Chromsome breakage (HP:0040012) | 2.06263651 |
88 | Increased serum lactate (HP:0002151) | 2.06253150 |
89 | Aplastic anemia (HP:0001915) | 2.05350450 |
90 | Abnormal trabecular bone morphology (HP:0100671) | 2.04170792 |
91 | Hyperactive renin-angiotensin system (HP:0000841) | 2.04121736 |
92 | Abdominal distention (HP:0003270) | 2.03690046 |
93 | Hypokalemia (HP:0002900) | 2.02157697 |
94 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.01950324 |
95 | Irregular vertebral endplates (HP:0003301) | 2.01533206 |
96 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.00923790 |
97 | Elevated alkaline phosphatase (HP:0003155) | 1.99386157 |
98 | Hepatic necrosis (HP:0002605) | 1.97143994 |
99 | Ependymoma (HP:0002888) | 1.95180969 |
100 | CNS hypomyelination (HP:0003429) | 1.94426678 |
101 | Deviation of the thumb (HP:0009603) | 1.93247495 |
102 | Steatorrhea (HP:0002570) | 1.92671328 |
103 | Autoimmune hemolytic anemia (HP:0001890) | 1.92164700 |
104 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.89445445 |
105 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.89445445 |
106 | Fasciculations (HP:0002380) | 1.89349135 |
107 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.89198064 |
108 | Decreased circulating renin level (HP:0003351) | 1.88581176 |
109 | Glycosuria (HP:0003076) | 1.87683498 |
110 | Abnormality of urine glucose concentration (HP:0011016) | 1.87683498 |
111 | Hyperammonemia (HP:0001987) | 1.86516254 |
112 | Abnormality of the metopic suture (HP:0005556) | 1.85313727 |
113 | Missing ribs (HP:0000921) | 1.84926526 |
114 | Lipid accumulation in hepatocytes (HP:0006561) | 1.84378268 |
115 | Dysautonomia (HP:0002459) | 1.84111208 |
116 | Increased hepatocellular lipid droplets (HP:0006565) | 1.83946125 |
117 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.83646636 |
118 | Epiphyseal stippling (HP:0010655) | 1.83329718 |
119 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.83328686 |
120 | Villous atrophy (HP:0011473) | 1.83328686 |
121 | Increased IgM level (HP:0003496) | 1.82217678 |
122 | Proximal placement of thumb (HP:0009623) | 1.81421629 |
123 | Lower limb hyperreflexia (HP:0002395) | 1.81396709 |
124 | Agnosia (HP:0010524) | 1.81308354 |
125 | Abnormality of methionine metabolism (HP:0010901) | 1.81147026 |
126 | Abnormality of the preputium (HP:0100587) | 1.80683172 |
127 | Proximal tubulopathy (HP:0000114) | 1.80566263 |
128 | Progressive neurologic deterioration (HP:0002344) | 1.79674399 |
129 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.79144812 |
130 | Abnormality of T cells (HP:0002843) | 1.78404506 |
131 | Progressive hearing impairment (HP:0001730) | 1.78291542 |
132 | Hyperparathyroidism (HP:0000843) | 1.78120513 |
133 | Hypoplasia of the pons (HP:0012110) | 1.77416304 |
134 | Neoplasm of the adrenal gland (HP:0100631) | 1.77185460 |
135 | Irritability (HP:0000737) | 1.76714861 |
136 | Unilateral renal agenesis (HP:0000122) | 1.76193576 |
137 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.76066971 |
138 | Glucose intolerance (HP:0000833) | 1.74931124 |
139 | Renal salt wasting (HP:0000127) | 1.74817945 |
140 | Squamous cell carcinoma (HP:0002860) | 1.72999445 |
141 | Increased CSF lactate (HP:0002490) | 1.72200108 |
142 | IgM deficiency (HP:0002850) | 1.72137894 |
143 | Premature ovarian failure (HP:0008209) | 1.71840881 |
144 | Osteomalacia (HP:0002749) | 1.71655790 |
145 | Hypophosphatemia (HP:0002148) | 1.70367826 |
146 | Abnormality of chloride homeostasis (HP:0011422) | 1.69960489 |
147 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.69957853 |
148 | Protuberant abdomen (HP:0001538) | 1.69791531 |
149 | Papillary thyroid carcinoma (HP:0002895) | 1.69227072 |
150 | Hyperphosphaturia (HP:0003109) | 1.68905693 |
151 | Poikiloderma (HP:0001029) | 1.68337024 |
152 | Acute hepatic failure (HP:0006554) | 1.68330836 |
153 | Hypobetalipoproteinemia (HP:0003563) | 1.68071130 |
154 | Hepatocellular necrosis (HP:0001404) | 1.67665055 |
155 | Poor head control (HP:0002421) | 1.67404771 |
156 | Nausea (HP:0002018) | 1.67043504 |
157 | Beaking of vertebral bodies (HP:0004568) | 1.66608213 |
158 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.66510203 |
159 | Opisthotonus (HP:0002179) | 1.66460708 |
160 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.65561960 |
161 | Abnormal epiphyseal ossification (HP:0010656) | 1.65293926 |
162 | Abnormal tarsal ossification (HP:0008369) | 1.65089148 |
163 | Spastic paraparesis (HP:0002313) | 1.64906903 |
164 | Lactic acidosis (HP:0003128) | 1.64693367 |
165 | Chronic bronchitis (HP:0004469) | 1.64318287 |
166 | Ragged-red muscle fibers (HP:0003200) | 1.63888976 |
167 | Prolonged neonatal jaundice (HP:0006579) | 1.62810638 |
168 | Onycholysis (HP:0001806) | 1.62722796 |
169 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.62635292 |
170 | Abnormality of the motor neurons (HP:0002450) | 1.61367729 |
171 | Abnormal neuron morphology (HP:0012757) | 1.61367729 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PASK | 4.46698245 |
2 | ERN1 | 3.54978440 |
3 | EIF2AK3 | 3.31189458 |
4 | BUB1 | 3.20111358 |
5 | BCR | 2.89416493 |
6 | BCKDK | 2.83349173 |
7 | TRIM28 | 2.55355036 |
8 | BRSK2 | 2.45891032 |
9 | SMG1 | 2.37432501 |
10 | SCYL2 | 2.35464546 |
11 | FLT3 | 2.35160978 |
12 | INSRR | 2.25498377 |
13 | TAOK3 | 2.24728970 |
14 | MST4 | 2.20841209 |
15 | TSSK6 | 2.18094934 |
16 | EIF2AK1 | 2.13036779 |
17 | FRK | 2.09857063 |
18 | VRK2 | 2.06821619 |
19 | TESK2 | 2.00684220 |
20 | IRAK3 | 1.98891378 |
21 | MST1R | 1.93774519 |
22 | EPHA2 | 1.86586660 |
23 | ACVR1B | 1.84786396 |
24 | MAPK15 | 1.78408182 |
25 | TESK1 | 1.77995232 |
26 | WEE1 | 1.70027521 |
27 | TAF1 | 1.59252478 |
28 | STK16 | 1.58080281 |
29 | CDC7 | 1.55015547 |
30 | PDK2 | 1.51114053 |
31 | MAP3K12 | 1.47515725 |
32 | ZAP70 | 1.39137009 |
33 | MAP3K3 | 1.35362038 |
34 | AKT3 | 1.33947654 |
35 | RPS6KB2 | 1.29596693 |
36 | HIPK2 | 1.28832678 |
37 | SIK3 | 1.27401751 |
38 | MET | 1.23888993 |
39 | ARAF | 1.23823857 |
40 | MAP3K2 | 1.20494240 |
41 | WNK3 | 1.18964100 |
42 | ERBB4 | 1.14403094 |
43 | PIM2 | 1.12057048 |
44 | ERBB3 | 1.11750346 |
45 | PTK6 | 1.08462486 |
46 | JAK3 | 1.07650017 |
47 | STK10 | 1.05173975 |
48 | CSNK1G3 | 1.05123772 |
49 | IRAK1 | 1.04866469 |
50 | ITK | 1.01354584 |
51 | CSNK1A1L | 1.00123450 |
52 | BRSK1 | 0.99834744 |
53 | PIK3CG | 0.99493016 |
54 | RPS6KA4 | 0.96852484 |
55 | CDK9 | 0.95502404 |
56 | IRAK4 | 0.95489910 |
57 | WNK4 | 0.94698000 |
58 | FER | 0.93956832 |
59 | KSR1 | 0.92675543 |
60 | DAPK1 | 0.91452684 |
61 | RIPK1 | 0.89291956 |
62 | MAP3K8 | 0.87777042 |
63 | MAP3K14 | 0.87692718 |
64 | LMTK2 | 0.87585186 |
65 | TEC | 0.87294688 |
66 | PTK2 | 0.82531375 |
67 | MAPKAPK5 | 0.81957465 |
68 | STK38L | 0.81151305 |
69 | ALK | 0.80565168 |
70 | ZAK | 0.78964791 |
71 | FGFR4 | 0.78746340 |
72 | NME1 | 0.78656106 |
73 | EIF2AK2 | 0.77821257 |
74 | NME2 | 0.76700126 |
75 | NEK1 | 0.76105298 |
76 | LIMK1 | 0.75101844 |
77 | CSNK1G1 | 0.74142710 |
78 | PAK4 | 0.73346313 |
79 | ATR | 0.72789051 |
80 | PRKCI | 0.72545848 |
81 | BTK | 0.71883516 |
82 | TTK | 0.70235898 |
83 | AURKB | 0.69593618 |
84 | VRK1 | 0.68611225 |
85 | NEK9 | 0.67483196 |
86 | TYK2 | 0.66356369 |
87 | CDK6 | 0.65329643 |
88 | ICK | 0.64353303 |
89 | NEK6 | 0.63595295 |
90 | PLK3 | 0.62729872 |
91 | MAP2K3 | 0.62390372 |
92 | MAP2K2 | 0.62230867 |
93 | MAPKAPK3 | 0.60713868 |
94 | PLK1 | 0.60375923 |
95 | CHEK2 | 0.60283703 |
96 | PLK4 | 0.58519924 |
97 | CSNK1G2 | 0.57844593 |
98 | MAP4K1 | 0.57334189 |
99 | CLK1 | 0.57211234 |
100 | LRRK2 | 0.56212507 |
101 | STK4 | 0.55898064 |
102 | STK3 | 0.55814760 |
103 | ATM | 0.55811264 |
104 | FGR | 0.55666073 |
105 | EPHB1 | 0.55255761 |
106 | EPHA3 | 0.53790697 |
107 | CDK12 | 0.53448743 |
108 | TBK1 | 0.52990584 |
109 | CSK | 0.51625436 |
110 | SRPK1 | 0.51118870 |
111 | CHUK | 0.50383521 |
112 | CDK8 | 0.50324261 |
113 | SIK1 | 0.48496423 |
114 | MAP3K5 | 0.47388414 |
115 | TGFBR1 | 0.47233150 |
116 | LATS1 | 0.47012223 |
117 | PBK | 0.46121205 |
118 | TLK1 | 0.45537612 |
119 | JAK2 | 0.44041767 |
120 | CAMKK2 | 0.43860433 |
121 | CHEK1 | 0.42846290 |
122 | MAP3K11 | 0.42619637 |
123 | AURKA | 0.42097003 |
124 | NEK2 | 0.42033443 |
125 | MKNK1 | 0.41838770 |
126 | EEF2K | 0.41759989 |
127 | DYRK3 | 0.40949312 |
128 | MAP3K1 | 0.39902565 |
129 | CSNK2A2 | 0.39516092 |
130 | CDK7 | 0.37466907 |
131 | BRAF | 0.37301157 |
132 | CSNK2A1 | 0.36919514 |
133 | NLK | 0.36836801 |
134 | CDK4 | 0.36069735 |
135 | CDK14 | 0.36040247 |
136 | JAK1 | 0.35950349 |
137 | PDGFRA | 0.35542550 |
138 | NUAK1 | 0.34882154 |
139 | CCNB1 | 0.34864902 |
140 | DYRK1B | 0.34323490 |
141 | CDK18 | 0.33024963 |
142 | AKT2 | 0.32246485 |
143 | CAMK1D | 0.31243553 |
144 | RAF1 | 0.26832654 |
145 | MAPKAPK2 | 0.26090654 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 5.76203412 |
2 | Protein export_Homo sapiens_hsa03060 | 5.19419052 |
3 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.22823697 |
4 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.05495548 |
5 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.72578654 |
6 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.45665298 |
7 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.40932703 |
8 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.23013772 |
9 | DNA replication_Homo sapiens_hsa03030 | 2.11204186 |
10 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.05903291 |
11 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.03224555 |
12 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.84853213 |
13 | Mismatch repair_Homo sapiens_hsa03430 | 1.82223210 |
14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.79815988 |
15 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.73805758 |
16 | Proteasome_Homo sapiens_hsa03050 | 1.65867248 |
17 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.55103410 |
18 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.53789733 |
19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.42767196 |
20 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.42036237 |
21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.39026371 |
22 | Other glycan degradation_Homo sapiens_hsa00511 | 1.36220240 |
23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.31912990 |
24 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.27741403 |
25 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.26461832 |
26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.26379598 |
27 | Galactose metabolism_Homo sapiens_hsa00052 | 1.25753584 |
28 | Lysosome_Homo sapiens_hsa04142 | 1.22157270 |
29 | Legionellosis_Homo sapiens_hsa05134 | 1.21280135 |
30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.19818137 |
31 | Base excision repair_Homo sapiens_hsa03410 | 1.15585928 |
32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.14003158 |
33 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.12979090 |
34 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.09798749 |
35 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.09557136 |
36 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.07755604 |
37 | RNA transport_Homo sapiens_hsa03013 | 1.03836705 |
38 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.02249457 |
39 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.01924515 |
40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.99223465 |
41 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.97844292 |
42 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.94061314 |
43 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.92804511 |
44 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.91347657 |
45 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.90986063 |
46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.90958591 |
47 | RNA polymerase_Homo sapiens_hsa03020 | 0.90811554 |
48 | Spliceosome_Homo sapiens_hsa03040 | 0.89716786 |
49 | Histidine metabolism_Homo sapiens_hsa00340 | 0.89098672 |
50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.87044037 |
51 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.84903466 |
52 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.84825890 |
53 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.84242520 |
54 | Homologous recombination_Homo sapiens_hsa03440 | 0.83433181 |
55 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.82400318 |
56 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.81818383 |
57 | Peroxisome_Homo sapiens_hsa04146 | 0.81696021 |
58 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.78994720 |
59 | Cell cycle_Homo sapiens_hsa04110 | 0.76971449 |
60 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.74217062 |
61 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.71381285 |
62 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.71187631 |
63 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.71131050 |
64 | Shigellosis_Homo sapiens_hsa05131 | 0.70411092 |
65 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.69607553 |
66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.69348337 |
67 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.68745403 |
68 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.68578976 |
69 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.68466403 |
70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.68098734 |
71 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.66897221 |
72 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.66277100 |
73 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.65133463 |
74 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.63391432 |
75 | Carbon metabolism_Homo sapiens_hsa01200 | 0.63149712 |
76 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.61944078 |
77 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.61466220 |
78 | Sulfur relay system_Homo sapiens_hsa04122 | 0.61438462 |
79 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.60694995 |
80 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.59256034 |
81 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.57794381 |
82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57607891 |
83 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.57040851 |
84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55820978 |
85 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.55226720 |
86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54750989 |
87 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.54403836 |
88 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54201596 |
89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52969948 |
90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52756651 |
91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52295407 |
92 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.50574749 |
93 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.49419204 |
94 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.49241984 |
95 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.48188725 |
96 | Apoptosis_Homo sapiens_hsa04210 | 0.45712698 |
97 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44437431 |
98 | Huntingtons disease_Homo sapiens_hsa05016 | 0.43527145 |
99 | Parkinsons disease_Homo sapiens_hsa05012 | 0.43399838 |
100 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.43001165 |
101 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.42910300 |
102 | Purine metabolism_Homo sapiens_hsa00230 | 0.40730721 |
103 | Salmonella infection_Homo sapiens_hsa05132 | 0.39866775 |
104 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.39722766 |
105 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.39512070 |
106 | Thyroid cancer_Homo sapiens_hsa05216 | 0.39318624 |
107 | ABC transporters_Homo sapiens_hsa02010 | 0.39298026 |
108 | Phagosome_Homo sapiens_hsa04145 | 0.39028850 |
109 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.36874567 |
110 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.35243719 |
111 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.34877765 |
112 | Measles_Homo sapiens_hsa05162 | 0.34855559 |
113 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.34154686 |
114 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.32854767 |
115 | Influenza A_Homo sapiens_hsa05164 | 0.31835614 |
116 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.31508384 |
117 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.30616889 |
118 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.29410436 |
119 | Bladder cancer_Homo sapiens_hsa05219 | 0.29327617 |
120 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.28911617 |
121 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.28820654 |
122 | RNA degradation_Homo sapiens_hsa03018 | 0.28381419 |
123 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.26707418 |
124 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.26118307 |
125 | Basal transcription factors_Homo sapiens_hsa03022 | 0.24552974 |
126 | Adherens junction_Homo sapiens_hsa04520 | 0.23320207 |
127 | Hepatitis B_Homo sapiens_hsa05161 | 0.22557318 |
128 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.20239665 |